Drug Shortage Report for OVIDREL
| Report ID | 233582 |
| Drug Identification Number | 02371588 |
| Brand name | OVIDREL |
| Common or Proper name | Choriogonadotropin alfa |
| Company Name | EMD SERONO, A DIVISION OF EMD INC., CANADA |
| Market Status | MARKETED |
| Active Ingredient(s) | CHORIOGONADOTROPIN ALFA |
| Strength(s) | 250MCG |
| Dosage form(s) | SOLUTION |
| Route of administration | SUBCUTANEOUS SUBCUTANEOUS |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 1 pen |
| ATC code | G03GA |
| ATC description | GONADOTROPHINS AND OTHER OVULATION STIMULANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2024-08-30 |
| Actual start date | 2024-09-02 |
| Estimated end date | 2025-12-31 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2025-01-06 |
| Company comments | OVIDREL SYRINGE (DIN 02262088) remains available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 2695 NORTH SHERIDAN WAY, SUITE 200 MISSISSAUGA, ONTARIO CANADA L5K 2N6 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2025-01-06 | French | Compare |
| v4 | 2025-01-06 | English | Compare |
| v3 | 2024-08-31 | English | Compare |
| v2 | 2024-07-23 | French | Compare |
| v1 | 2024-07-23 | English | Compare |
Showing 1 to 5 of 5